Atopic dermatitis (AD) is typically a big issue during early childhood. But it also afflicts up to 5% of adults. Mild cases, which are virtually always managed in primary care, are usually ...

The results suggest dupilumab may offer consistent benefit across patient subgroups without the need for extensive ...

Dupilumab treatment in atopic dermatitis patients shows a 58% higher risk of developing psoriasis compared to other systemic treatments. The number needed to harm is 94, indicating a limited absolute ...

Please provide your email address to receive an email when new articles are posted on . Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents ...